Search

MacroGenics Inc

Chiusa

SettoreSettore sanitario

4.48 8.47

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

4.02

Massimo

4.51

Metriche Chiave

By Trading Economics

Entrata

-23M

-37M

Vendite

-20M

21M

EPS

-0.58

Margine di Profitto

-177.011

Dipendenti

293

EBITDA

-15M

-30M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+40.98% upside

Dividendi

By Acuity

Utili prossimi

12 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

88M

275M

Apertura precedente

-3.99

Chiusura precedente

4.48

Notizie sul Sentiment di mercato

By Acuity

19%

81%

32 / 340 Classifica in Healthcare

MacroGenics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 lug 2026, 23:56 UTC

News
Social Media

Micron Technology shares are lower in after-market trading amid a decline in India's smartphone shipments and ongoing memory cost pressures affecting margins.

17 lug 2026, 23:36 UTC

News

GameStop increased its stake in eBay to nearly 10%, acquiring 3.5 million shares for about $381 million. eBay shares are gaining in after-market trading.

17 lug 2026, 23:36 UTC

Macro News
News
ETF Constituents

Vanguard Information Technology ETF rises slightly in after-market trading, supported by gains in Microsoft, Analog Devices, Adobe, Qualcomm, and Snowflake.

17 lug 2026, 23:21 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares declined in after-market trading amid concerns over $125 billion to $145 billion in projected AI spending and slower development timelines.

17 lug 2026, 23:16 UTC

News

United Airlines reported record Q2 revenue of $17.7 billion, a 16% increase. Shares were little changed during after-market hours following the announcement.

17 lug 2026, 23:16 UTC

News
Social Media

PayPal Holdings Inc shares are lower in after-market trading amid reports of a potential bid, though analysts remain cautious about growth prospects.

17 lug 2026, 23:16 UTC

News
ETF Constituents
Macro News
Correlated Moves

GDX trades higher in after-market hours, supported by positive analysis and strong performance expectations amid rising geopolitical tensions and crude oil prices.

17 lug 2026, 23:06 UTC

News

Baidu Inc. partners with Apple to enhance its AI capabilities and pursues a dual-primary listing in Hong Kong, shares higher in after-market trading.

17 lug 2026, 23:06 UTC

ETF Constituents
News

Vanguard Growth ETF trades lower in after-market hours, continuing a downward trend. Top holdings META, AMAT, and LLY negatively impacted performance.

17 lug 2026, 20:07 UTC

News
Social Media

European Union approval is anticipated for the $55 billion acquisition of Electronic Arts by a group of investors, including Saudi Arabia's Public Investment Fund.

17 lug 2026, 20:07 UTC

News
Social Media

Tesla Inc shares are lower as investors await the earnings report on July 22. Concerns over Semi truck rollout and autonomous driving goals weigh on sentiment.

17 lug 2026, 20:07 UTC

Macro Event
Social Media
Correlated Moves
News

Broadcom shares declined to around $371.69 today, amid increased bearish sentiment and concerns over potential breakdowns below key support levels.

17 lug 2026, 20:07 UTC

News

Ethereum is trading lower as geopolitical tensions and rising oil prices heighten inflation concerns. Ongoing worries about tech valuations also impact its performance.

17 lug 2026, 20:07 UTC

News

Bitcoin is rising during Friday's session amid geopolitical tensions and rising oil prices, though it has pulled back from earlier session highs.

17 lug 2026, 20:07 UTC

News
Macro Event

Geopolitical tensions and rising oil prices support Bitcoin's gains during Friday's session, despite earlier pullbacks and regulatory scrutiny from former President Trump.

17 lug 2026, 20:03 UTC

News

J B Hunt shares are lower as freight shipments decline and inflationary pressures persist. The Cass Freight Index reported a 4.1% year-over-year drop in June.

17 lug 2026, 20:03 UTC

News
Social Media
Correlated Moves

Western Digital Corp shares are higher, supported by projected revenue growth of 43.7% and improved operating margins, despite earlier volatility and a pullback from session highs.

17 lug 2026, 20:03 UTC

News
Macro Event

Ulta Beauty is gaining as Evercore highlights its innovation amid positive consumer sentiment data, despite an earlier pullback from session highs.

17 lug 2026, 20:03 UTC

Correlated Moves
News
Social Media

Alphabet Inc. shares are declining amid reports of delays in the Gemini project rollout, overshadowing BMO's price target increase to $455.

17 lug 2026, 20:03 UTC

News
Correlated Moves
Social Media

Alphabet Inc shares are lower amid a securities fraud investigation and delays in its AI model rollout. BMO raised its price target to $455.

17 lug 2026, 20:02 UTC

News

Wynn Resorts Ltd is lower amid broader market declines and a negative outlook from StockStory, citing financial challenges and modest sales growth.

17 lug 2026, 20:01 UTC

News

NetApp Inc. shares are higher as StockStory highlights a $177.25 price target and strong growth in billings and earnings per share.

17 lug 2026, 19:56 UTC

News

Gilead Sciences shares are lower as the company missed full-year EPS estimates despite reporting $6.96 billion in revenue, reflecting heightened market volatility.

17 lug 2026, 19:56 UTC

News
Social Media

Apple Inc. is in early settlement discussions regarding an antitrust lawsuit. The company regained its status as the world's most valuable, surpassing Nvidia.

17 lug 2026, 19:52 UTC

News
Social Media
Correlated Moves

NVIDIA shares are declining amid a broader semiconductor sell-off and competitive concerns from Moonshot AI's new model. Apple has surpassed NVIDIA in market value.

17 lug 2026, 19:52 UTC

News
Correlated Moves

NXP Semiconductors NV is trading lower amid a broader market decline and rising pressures in the semiconductor industry, impacting its valuation narrative.

17 lug 2026, 19:52 UTC

News
Social Media
Correlated Moves

AMD declines today amid broader market losses, pulling back from session high.

17 lug 2026, 19:46 UTC

Social Media
News
Macro Event

Shares of American Airlines are lower today, trading around $15.03 amid increased bearish sentiment reflected in a rising put/call ratio of 1.61.

17 lug 2026, 19:46 UTC

Social Media
Correlated Moves
News

CSX shares are lower as Daniel Loeb exits his 500,000-share position, following significant cuts in other railroad investments amid regulatory scrutiny.

17 lug 2026, 19:46 UTC

News
Macro Event

Autodesk announces a collaboration with Amazon Web Services and raises revenue guidance to $8.5 billion, as shares gain during Friday's session.

Confronto tra pari

Modifica del prezzo

MacroGenics Inc Previsione

Obiettivo di Prezzo

By TipRanks

40.98% in crescita

Previsioni per 12 mesi

Media 6.33 USD  40.98%

Alto 9 USD

Basso 4 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per MacroGenics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

32 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo MacroGenics Inc

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
help-icon Live chat